THERESE BRANDON: Open Payments
NPI 1134190523 · INDIANAPOLIS, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$528 in 23 payments from 11 companies in 2025. Trend: 2023 $442 · 2024 $468 · 2025 $528
Food & beverage: $528
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | 4 | $157 |
| Novo Nordisk Inc | 4 | $85 |
| Abbott Laboratories | 2 | $48 |
| Medtronic, Inc. | 2 | $48 |
| SCPHARMACEUTICALS INC. | 2 | $42 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 4 | $41 |
| Novartis Pharmaceuticals Corporation | 1 | $26 |
| AstraZeneca Pharmaceuticals LP | 1 | $24 |
| BridgeBio Pharma, Inc. | 1 | $21 |
| Philips North America LLC | 1 | $19 |
Products named: CAMZYOS, Ozempic, FUROSCIX, LifeVest, LINQ II, LEQVIO, PERCLOSE PROSTYLE, MITRACLIP.
Industry payments across IN — which companies pay providers there.
